A citation-based method for searching scientific literature

Alessio Basolo, Antonio Matrone, Rossella Elisei, Ferruccio Santini. Semin Cancer Biol 2022
Times Cited: 8







List of co-cited articles
57 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Identification of a Water-Soluble Indirubin Derivative as Potent Inhibitor of Insulin-like Growth Factor 1 Receptor through Structural Modification of the Parent Natural Molecule.
Xinlai Cheng, Karl-Heinz Merz, Sandra Vatter, Jochen Zeller, Stephan Muehlbeyer, Andrea Thommet, Jochen Christ, Stefan Wölfl, Gerhard Eisenbrand. J Med Chem 2017
21
12

Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells.
Sangkil Nam, Ralf Buettner, James Turkson, Donghwa Kim, Jin Q Cheng, Stephan Muehlbeyer, Frankie Hippe, Sandra Vatter, Karl-Heinz Merz, Gerhard Eisenbrand,[...]. Proc Natl Acad Sci U S A 2005
225
12

A representative of arylcyanomethylenequinone oximes effectively inhibits growth and formation of hyphae in Candida albicans and influences the activity of protein kinases in vitro.
Maciej Masłyk, Monika Janeczko, Oleg M Demchuk, Anna Boguszewska-Czubara, Hieronim Golczyk, Anna Sierosławska, Anna Rymuszka, Aleksandra Martyna, Konrad Kubiński. Saudi Pharm J 2018
3
33

Characterization of the Indirubin Derivative LDD970 as a Small Molecule Aurora Kinase A Inhibitor in Human Colorectal Cancer Cells.
Karyn Muzinga Ndolo, Kyeong Ryang Park, Hyo Jeong Lee, Kyoung Bin Yoon, Yong-Chul Kim, Sun-Young Han. Immune Netw 2017
9
12

Biochemical markers for blood-brain barrier dysfunction in acute ischemic stroke correlate with evolution and outcome.
Raf Brouns, Annick Wauters, Didier De Surgeloose, Peter Mariën, Peter P De Deyn. Eur Neurol 2011
64
12

Discovery of novel indirubin-3'-monoxime derivatives as potent inhibitors against CDK2 and CDK9.
Lei Yan, Fangfang Lai, Xiaoguang Chen, Zhiyan Xiao. Bioorg Med Chem Lett 2015
22
12

Therapeutic Effects of Tryptanthrin and Tryptanthrin-6-Oxime in Models of Rheumatoid Arthritis.
Liliya N Kirpotina, Igor A Schepetkin, Deepa Hammaker, Amanda Kuhs, Andrei I Khlebnikov, Mark T Quinn. Front Pharmacol 2020
9
12

Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3.
Michael Martin, Kunal Rehani, Richard S Jope, Suzanne M Michalek. Nat Immunol 2005
860
12


Identification of chemically diverse Chk1 inhibitors by receptor-based virtual screening.
Nicolas Foloppe, Lisa M Fisher, Rob Howes, Andrew Potter, Alan G S Robertson, Allan E Surgenor. Bioorg Med Chem 2006
86
12

Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases.
R Hoessel, S Leclerc, J A Endicott, M E Nobel, A Lawrie, P Tunnah, M Leost, E Damiens, D Marie, D Marko,[...]. Nat Cell Biol 1999
567
12

Synthesis and evaluation of 3-ylideneoxindole acetamides as potent anticancer agents.
Chun-Tang Chiou, Wei-Chun Lee, Jiahn-Haur Liao, Jing-Jy Cheng, Lie-Chwen Lin, Chih-Yu Chen, Jen-Shin Song, Ming-Hsien Wu, Kak-Shan Shia, Wen-Tai Li. Eur J Med Chem 2015
17
12

Entry of oximes into the brain: a review.
D E Lorke, H Kalasz, G A Petroianu, K Tekes. Curr Med Chem 2008
115
12

Anti-Inflammatory Effects and Joint Protection in Collagen-Induced Arthritis after Treatment with IQ-1S, a Selective c-Jun N-Terminal Kinase Inhibitor.
Igor A Schepetkin, Liliya N Kirpotina, Deepa Hammaker, Irina Kochetkova, Andrei I Khlebnikov, Sergey A Lyakhov, Gary S Firestein, Mark T Quinn. J Pharmacol Exp Ther 2015
29
12

7-Bromoindirubin-3'-oxime induces caspase-independent cell death.
J Ribas, K Bettayeb, Y Ferandin, M Knockaert, X Garrofé-Ochoa, F Totzke, C Schächtele, J Mester, P Polychronopoulos, P Magiatis,[...]. Oncogene 2006
76
12

TRPA1 modulation of spontaneous and mechanically evoked firing of spinal neurons in uninjured, osteoarthritic, and inflamed rats.
Steve McGaraughty, Katharine L Chu, Richard J Perner, Stan Didomenico, Michael E Kort, Philip R Kym. Mol Pain 2010
124
12


Recent developments in the chemistry and in the biological applications of amidoximes.
K C Fylaktakidou, D J Hadjipavlou-Litina, K E Litinas, E A Varella, D N Nicolaides. Curr Pharm Des 2008
42
12

E/Z oxime isomerism in PhC(NOH)CN.
D Scott Bohle, Zhijie Chua, Inna Perepichka, Kristopher Rosadiuk. Chemistry 2013
11
12

KF25706, a novel oxime derivative of radicicol, exhibits in vivo antitumor activity via selective depletion of Hsp90 binding signaling molecules.
S Soga, L M Neckers, T W Schulte, Y Shiotsu, K Akasaka, H Narumi, T Agatsuma, Y Ikuina, C Murakata, T Tamaoki,[...]. Cancer Res 1999
131
12

Vasorelaxant activity of some oxime derivatives.
Filip Jaros, Tomás Straka, Zdenka Dobesová, Mária Pintérová, Karel Chalupský, Jaroslav Kunes, Gustav Entlicher, Josef Zicha. Eur J Pharmacol 2007
10
12

The cyclin-dependent kinases pathway as a target for prostate cancer treatment: rationale and future perspectives.
Nicole Brighi, Vincenza Conteduca, Cristian Lolli, Giorgia Gurioli, Giuseppe Schepisi, Michela Palleschi, Marita Mariotti, Chiara Casadei, Ugo De Giorgi. Crit Rev Oncol Hematol 2021
7
14

Structure-activity relationship study of androstene steroids with respect to local anti-inflammatory activity.
Rohini Chaubal, Arvind M Mujumdar, Ashwini Misar, Vishnu H Deshpande, Nirmala R Deshpande. Arzneimittelforschung 2006
5
20


Indirubin derivatives as potent FLT3 inhibitors with anti-proliferative activity of acute myeloid leukemic cells.
Soo Jeong Choi, Myoung Ju Moon, So Deok Lee, Sang-Un Choi, Sun-Young Han, Yong-Chul Kim. Bioorg Med Chem Lett 2010
23
12

The identification of potent and selective imidazole-based inhibitors of B-Raf kinase.
Andrew K Takle, Murray J B Brown, Susannah Davies, David K Dean, Gerraint Francis, Alessandra Gaiba, Alex W Hird, Frank D King, Peter J Lovell, Antoinette Naylor,[...]. Bioorg Med Chem Lett 2006
67
12

Interactions of janus kinase inhibitors with drug transporters and consequences for pharmacokinetics and toxicity.
Karima Alim, Arnaud Bruyère, Alain Lescoat, Elodie Jouan, Valérie Lecureur, Marc Le Vée, Olivier Fardel. Expert Opin Drug Metab Toxicol 2021
6
16

Induction of cell death in pancreatic ductal adenocarcinoma by indirubin 3'-oxime and 5-methoxyindirubin 3'-oxime in vitro and in vivo.
Makoto Sano, Yoshimi Ichimaru, Masahiro Kurita, Emiko Hayashi, Taku Homma, Hiroaki Saito, Shinobu Masuda, Norimichi Nemoto, Akihiro Hemmi, Takashi Suzuki,[...]. Cancer Lett 2017
13
12

5-Nitro-5'-hydroxy-indirubin-3'-oxime (AGM130), an indirubin-3'-oxime derivative, inhibits tumor growth by inducing apoptosis against non-small cell lung cancer in vitro and in vivo.
Mee-Young Ahn, Tae-Hyung Kim, Seong-Min Kwon, Hyo-Eun Yoon, Hyung-Sik Kim, Jae-Il Kim, Yong-Chul Kim, Keon-Wook Kang, Sang-Gun Ahn, Jung-Hoon Yoon. Eur J Pharm Sci 2015
23
12

A novel non-NMDA receptor antagonist shows selective displacement of low-affinity [3H]kainate binding.
T H Johansen, J Drejer, F Wätjen, E O Nielsen. Eur J Pharmacol 1993
78
12

Aurora Kinase Inhibitors in Oncology Clinical Trials: Current State of the Progress.
Gerald S Falchook, Christel C Bastida, Razelle Kurzrock. Semin Oncol 2015
69
12


MLS-2384, a new 6-bromoindirubin derivative with dual JAK/Src kinase inhibitory activity, suppresses growth of diverse cancer cells.
Lucy Liu, Nicolas Gaboriaud, Konstantina Vougogianopoulou, Yan Tian, Jun Wu, Wei Wen, Leandros Skaltsounis, Richard Jove. Cancer Biol Ther 2014
23
12

JNK selective inhibitor, IQ-1S, protects the mice against lipopolysaccharides-induced sepsis.
Zhelong Nie, Xiaoli Xia, Yang Zhao, Sheng Zhang, Yanwei Zhang, Junhui Wang. Bioorg Med Chem 2021
3
33

Indirubin-3-Oxime Prevents H2O2-Induced Neuronal Apoptosis via Concurrently Inhibiting GSK3β and the ERK Pathway.
Jie Yu, Jiacheng Zheng, Jiajia Lin, Linlu Jin, Rui Yu, Shinghung Mak, Shengquan Hu, Hongya Sun, Xiang Wu, Zaijun Zhang,[...]. Cell Mol Neurobiol 2017
16
12


Indirubin derivatives induce apoptosis of chronic myelogenous leukemia cells involving inhibition of Stat5 signaling.
Sangkil Nam, Anna Scuto, Fan Yang, Wenyong Chen, Sungman Park, Hwa-Seung Yoo, Heiko Konig, Ravi Bhatia, Xinlai Cheng, Karl-Heinz Merz,[...]. Mol Oncol 2012
50
12


Relaxant effect of oxime derivatives in isolated rat aorta: role of nitric oxide (NO) formation in smooth muscle.
Karel Chalupsky, Irina Lobysheva, Françoise Nepveu, Irina Gadea, Petra Beranova, Gustav Entlicher, Jean-Claude Stoclet, Bernard Muller. Biochem Pharmacol 2004
27
12



The specificities of protein kinase inhibitors: an update.
Jenny Bain, Hilary McLauchlan, Matthew Elliott, Philip Cohen. Biochem J 2003
12



NO-donating oximes relax corpora cavernosa through mechanisms other than those involved in arterial relaxation.
Bart Pauwels, Charlotte Boydens, Kelly Decaluwé, Johan Van de Voorde. J Sex Med 2014
5
20

Synthesis and anti-inflammatory evaluation of 4-anilinofuro[2,3-b]quinoline and 4-phenoxyfuro[2,3-b]quinoline derivatives. Part 3.
Yeh-Long Chen, I-Li Chen, Chih-Ming Lu, Cherng-Chyi Tzeng, Lo-Ti Tsao, Jih-Pyang Wang. Bioorg Med Chem 2004
24
12

16α,17α-Epoxypregnenolone-20-oxime prevent LPS-induced NO production and iNOS expression in BV-2 microglial cells by inhibiting JNK phosphorylation.
Hu-Nan Sun, Mei-Hua Jin, Bing Han, Li Feng, Ying-Hao Han, Gui-Nan Shen, Yong-Zhong Yu, Cheng-Hao Jin, Zheng-Xing Lian, Dong-Soek Lee,[...]. Biol Pharm Bull 2014
5
20

Development and validation of a FIA/UV-vis method for pK(a) determination of oxime based acetylcholinesterase reactivators.
Karel Musil, Veronika Florianova, Pavel Bucek, Vlastimil Dohnal, Kamil Kuca, Kamil Musilek. J Pharm Biomed Anal 2016
19
12

Design, Synthesis, and Biological Evaluation of Novel Thiazolyl Substituted Bis-pyrazole Oxime Derivatives with Potent Antitumor Activities by Selectively Inducing Apoptosis and ROS in Cancer Cells.
Biao Xiong, Shi Chen, Peng Zhu, Meiling Huang, Weijie Gao, Rui Zhu, Jianqiang Qian, Yanfu Peng, Yanan Zhang, Hong Dai,[...]. Med Chem 2019
5
20

Potent and selective pyrazole-based inhibitors of B-Raf kinase.
Joshua D Hansen, Jonas Grina, Brad Newhouse, Mike Welch, George Topalov, Nicole Littman, Michele Callejo, Susan Gloor, Matthew Martinson, Ellen Laird,[...]. Bioorg Med Chem Lett 2008
52
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.